Healthcare [ 7/13 ] | Biotechnology [ 82/163 ]
NASDAQ | Common Stock
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies.
It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor.
It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT.
BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 14, 24 | 0.11 Increased by +114.29% | -0.55 Increased by +120.00% |
| Mar 18, 24 | -0.71 Decreased by -914.29% | -0.20 Decreased by -255.00% |
| Dec 14, 23 | -0.50 Increased by +50.98% | -0.18 Decreased by -177.78% |
| Oct 25, 23 | -0.15 Increased by +53.13% | -0.39 Increased by +61.54% |
| Mar 15, 23 | -0.77 Decreased by -220.83% | -0.35 Decreased by -120.00% |
| Dec 14, 22 | -0.07 Increased by +56.25% | -0.33 Increased by +78.79% |
| Oct 27, 22 | -1.02 Decreased by -268.09% | -0.35 Decreased by -191.43% |
| Jun 13, 22 | -0.32 Decreased by -9.70% | -0.17 Decreased by -88.24% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Apr 30, 24 | 0.00 Decreased by N/A% | 1.69 M Increased by +138.71% | Increased by +N/A% Decreased by N/A% |
| Jan 31, 24 | 0.00 Decreased by N/A% | -11.36 M Increased by +4.39% | Decreased by N/A% Decreased by N/A% |
| Oct 31, 23 | 0.00 Decreased by N/A% | 6.00 M Increased by +88.13% | Increased by +N/A% Decreased by N/A% |
| Jul 31, 23 | 0.00 Decreased by N/A% | -2.42 M Increased by +86.23% | Decreased by N/A% Decreased by N/A% |
| Apr 30, 23 | 0.00 Decreased by N/A% | -4.37 M Increased by +52.63% | Decreased by N/A% Decreased by N/A% |
| Jan 31, 23 | 0.00 Decreased by N/A% | -11.88 M Decreased by -640.37% | Decreased by N/A% Decreased by N/A% |
| Oct 31, 22 | 0.00 Decreased by N/A% | 3.19 M Increased by +258.02% | Increased by +N/A% Decreased by N/A% |
| Jul 31, 22 | 0.00 Decreased by N/A% | -17.56 M Decreased by -1.79 K% | Decreased by N/A% Decreased by N/A% |